New Product Marketing Blurs the Line Between Nicotine Replacement Therapy and Smokeless Tobacco Products

    loading  Checking for direct PDF access through Ovid

Abstract

ABSTRACT

Tobacco companies have begun to acquire pharmaceutical subsidiaries and recently started to market nicotine replacement therapies, such as Zonnic nicotine gum, in convenience stores.

Conversely, tobacco companies are producing tobacco products such as tobacco chewing gum and lozenges that resemble pharmaceutical nicotine replacement products, including a nicotine pouch product that resembles snus pouches.

This convergence of nicotine and tobacco product marketing has implications for regulation and tobacco cessation.

Related Topics

    loading  Loading Related Articles